\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ examination\\,\\ she\\ had\\ terminal\\ neck\\ stiffness\\,\\ sluggishly\\ reacting\\ right\\ pupil\\,\\ left\\ hemiparesis\\,\\ left\\ upper\\ motor\\ neuron\\ facial\\ palsy\\,\\ and\\ right\\ sided\\ optic\\ atrophy\\.\ \(0\)\
\-\ investigations\\ showed\\ anaemia\\ and\\ raised\\ erythrocyte\\ sedimentation\\ rate\\ \\(esr\\)\\.\ \(0\)\
\-\ magnetic\\ resonance\\ imaging\\ \\(mri\\)\\ of\\ the\\ brain\\ revealed\\ an\\ infarct\\ involving\\ \\ the\\ right\\ middle\\ cerebral\\ artery\\ region\\ \\,\\ thick\\ enhancing\\ exudates\\ along\\ the\\ cortical\\ sulci\\ and\\ basal\\ cisterns\\,\\ and\\ features\\ suggestive\\ of\\ tuberculous\\ meningitis\\ \ \(0\)\
\-\ mri\\ also\\ showed\\ a\\ 2\\ cm\\ x\\ 1\\.8\\ cm\\ x\\ 1\\.8\\ cm\\ mass\\ in\\ the\\ supra\\-sellar\\ cistern\\ which\\ was\\ isointense\\ on\\ t1\\ weighted\\ images\\ and\\ hypointense\\ on\\ t2\\ weighted\\ and\\ fluid\\ attenuated\\ inversion\\ recovery\\ \\(flair\\)\\ images\\ \\(figure\\ 2\\)\\.\\ hypointensity\\ on\\ t2\\ weighted\\ imaging\\ is\\ characteristic\\ of\\ caseous\\ necrotic\\ content\\.\ \(0\)\
\-\ cerebrospinal\\ fluid\\ \\(csf\\)\\ analysis\\ showed\\ 5\\ cells\\ \\(100\\%\\ lymphocytes\\)\\,\\ 20\\ mg\\/dl\\ proteins\\,\\ and\\ 45\\ mg\\/dl\\ of\\ glucose\\.\\ csf\\ adenosine\\ deaminase\\ \\(ada\\)\\ level\\ was\\ 22\\ u\\/l\\ \\(normal\\ \\<10u\\/l\\)\\.\\ immunoglobulin\\ m\\ \\(igm\\)\\ for\\ anti\\-a60\\ antigen\\ was\\ positive\\.\\ \ \(0\)\
\-\ cortisol\\,\\ adrenocorticotropic\\ hormone\\ \\(acth\\)\\,\\ follicle\\ stimulating\\ hormone\\ \\(fsh\\)\\,\\ leutinising\\ hormone\\ \\(lh\\)\\,\\ prolactin\\,\\ t3\\,\\ t4\\,\\ and\\ thyroid\\ stimulating\\ hormone\\ \\(tsh\\)\\ levels\\ were\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ the\\ above\\ clinical\\,\\ laboratory\\,\\ and\\ mri\\ findings\\ were\\ suggestive\\ of\\ a\\ tuberculoma\\;\\ however\\,\\ a\\ malignancy\\ had\\ to\\ be\\ reliably\\ ruled\\ out\\.\\ in\\ view\\ of\\ her\\ pregnant\\ state\\,\\ magnetic\\ resonance\\ spectroscopy\\ was\\ performed\\ in\\ lieu\\ of\\ transnasal\\ suprasellar\\ biopsy\\.\ \(0\)\
\-\ mr\\ spectroscopy\\ revealed\\ a\\ prominent\\ lipid\\ peak\\ at\\ 1\\.3\\ ppm\\,\\ typical\\ of\\ a\\ tuberculoma\\ \\(figures\\ 3\\ and\\ 4\\)\\.\ \(0\)\
\-\ anti\\-tuberculous\\ drugs\\ and\\ intravenous\\ steroids\\ were\\ started\\.\\ there\\ was\\ marked\\ clinical\\ improvement\\ over\\ the\\ following\\ weeks\\.\\ she\\ was\\ discharged\\ and\\ advised\\ regular\\ physiotherapy\\ and\\ follow\\-up\\ with\\ repeat\\ mri\\ after\\ 3\\ months\ \(0\)\
\-\ mri\\ reveals\\ suprasellar\\ mass\\ lesion\\ which\\ is\\ isointense\\ on\\ t1\\ w\\ images\\ and\\ hypointense\\ on\\ t2\\ w\\ images\\ with\\ enahncing\\ exudateds\\ along\\ cortical\\ sulci\\ and\\ in\\ sylvian\\ fissure\\ with\\ vasculitis\\ \\-\\ ischemic\\ changes\\ in\\ right\\ basal\\ ganglion\\.\ \(0\)\
\-\ on\\ mr\\ spectroscopy\\ \\ a\\ prominent\\ lipid\\ peak\\ at\\ 1\\.3\\ ppm\\ characteristic\\ of\\ a\\ tuberculoma\\.\ \(0\)\
\-\ pituitary\\ tuberculosis\ \(0\)\
\-\ cavernous\\ sinus\\ mass\ \(0\)\
\-\ \\Â\\»\\ meningioma\ \(0\)\
\-\ \\Â\\»\\ schwannoma\ \(0\)\
\-\ \\Â\\»\\ lymphoma\ \(1\)\
\-\ a\\ 20\\ year\\ old\\ woman\\ presented\\ with\\ sudden\\ onset\\ depressed\\ sensorium\\ and\\ left\\ sided\\ weakness\\.\\ she\\ was\\ 20\\ weeks\\ pregnant\\ and\\ had\\ a\\ 6\\ month\\ history\\ of\\ low\\ grade\\ fever\\ and\\ occasional\\ vomiting\\.\\ she\\ had\\ no\\ past\\ history\\ of\\ gastric\\ or\\ esophageal\\ disorder\\,\\ tuberculosis\\,\\ diabetes\\,\\ or\\ any\\ other\\ major\\ illness\\.\ \(0\)\
\-\ hypointensity\\ on\\ t2\\ weighted\\ imaging\\ is\\ characteristic\\ of\\ caseous\\ necrotic\\ content\ \(0\)\
\-\ mr\\ spectroscopy\\ revealed\\ a\\ prominent\\ lipid\\ peak\\ at\\ 1\\.3\\ ppm\\,\\ typical\\ of\\ a\\ tuberculoma\\ \ \(0\)\
\-\ case\\ contributors\\:\ \(0\)\
\-\ dr\\ altaf\\ patel\\,\\ m\\.d\\.\\ hou\ \(0\)\
\-\ dept\\ of\\ medicine\\,\\ sir\\ j\\ j\\ hospital\ \(0\)\
\-\ mumbai\\,\\ india\ \(0\)\
\-\ dr\\ w\\ a\\ shaikh\\,\\ m\\.d\\.\ \(0\)\
\-\ dr\\ sona\\ pungaokar\\,m\\.d\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tuberculoma\\:\\ 0\\.056965063332271915\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.051485638980019385\ \(0\)\
\-\ ppm\\:\\ 0\\.044046782981303996\ \(0\)\
\-\ hormone\\:\\ 0\\.038302185853078076\ \(0\)\
\-\ m\\.d\\:\\ 0\\.03804914911759759\ \(0\)\
\-\ lipid\\:\\ 0\\.034504660970825135\ \(0\)\
\-\ dr\\:\\ 0\\.033939580853408195\ \(0\)\
\-\ w\\:\\ 0\\.03342370312422066\ \(0\)\
\-\ 1\\.3\\:\\ 0\\.032725384731001\ \(0\)\
\-\ caseous\\:\\ 0\\.03210423416366226\ \(0\)\
\-\ weighted\\:\\ 0\\.029372743052508296\ \(0\)\
\-\ peak\\:\\ 0\\.028839573352085396\ \(0\)\
\-\ stimulating\\:\\ 0\\.025742819490009693\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.02496253896034628\ \(0\)\
\-\ content\\:\\ 0\\.02281026081519002\ \(0\)\
\-\ 1\\.8\\:\\ 0\\.021673177524866773\ \(0\)\
\-\ characteristic\\:\\ 0\\.021444790865814262\ \(0\)\
\-\ hypointensity\\:\\ 0\\.021400478428080405\ \(0\)\
\-\ prominent\\:\\ 0\\.020793976639715175\ \(0\)\
\-\ \\(\\:\\ 0\\.019986292820976376\ \(0\)\
\-\ pregnant\\:\\ 0\\.019886675059479195\ \(0\)\
\-\ resonance\\:\\ 0\\.019797849542277385\ \(0\)\
\-\ \\)\\:\\ 0\\.01974214958416259\ \(0\)\
\-\ mri\\:\\ 0\\.0193999590406583\ \(0\)\
\-\ magnetic\\:\\ 0\\.019381404816357122\ \(0\)\
\-\ sulci\\:\\ 0\\.019303133562222023\ \(0\)\
\-\ t2\\:\\ 0\\.019119278804350607\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.019004684738079158\ \(0\)\
\-\ she\\:\\ 0\\.01896273629608041\ \(0\)\
\-\ necrotic\\:\\ 0\\.018467919753260734\ \(0\)\
\-\ suprasellar\\:\\ 0\\.018405673283030933\ \(0\)\
\-\ 20\\:\\ 0\\.018216493495002067\ \(0\)\
\-\ sluggishly\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ reacting\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ deaminase\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ ada\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ 10u\\/l\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ anti\\-a60\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ adrenocorticotropic\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ leutinising\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ lieu\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ transnasal\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ anti\\-tuberculous\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ physiotherapy\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ enahncing\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ exudateds\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ altaf\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ hou\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ mumbai\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ shaikh\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ sona\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ pungaokar\\:\\ 0\\.017421973169894266\ \(0\)\
\-\ showed\\:\\ 0\\.016611481825634565\ \(0\)\
\-\ isointense\\:\\ 0\\.016602363269269716\ \(0\)\
\-\ revealed\\:\\ 0\\.016259726619759444\ \(0\)\
\-\ mr\\:\\ 0\\.016098020584662653\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.016089273895665012\ \(0\)\
\-\ anaemia\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ supra\\-sellar\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ adenosine\\:\\ 0\\.01605211708183113\ \(0\)\
\-\ \\,\\:\\ 0\\.016050003884424152\ \(0\)\
\-\ hypointense\\:\\ 0\\.016021124463117556\ \(0\)\
\-\ basal\\:\\ 0\\.015397381415566692\ \(0\)\
\-\ j\\:\\ 0\\.015255697100257854\ \(0\)\
\-\ exudates\\:\\ 0\\.01525080263892962\ \(0\)\
\-\ reliably\\:\\ 0\\.01525080263892962\ \(0\)\
\-\ sir\\:\\ 0\\.01525080263892962\ \(0\)\
\-\ follicle\\:\\ 0\\.014682260993767998\ \(0\)\
\-\ patel\\:\\ 0\\.014682260993767998\ \(0\)\
\-\ had\\:\\ 0\\.014575887899136032\ \(0\)\
\-\ suggestive\\:\\ 0\\.014429772529814167\ \(0\)\
\-\ sensorium\\:\\ 0\\.014241265833067979\ \(0\)\
\-\ csf\\:\\ 0\\.01410472075812653\ \(0\)\
\-\ fsh\\:\\ 0\\.013880946550866488\ \(0\)\
\-\ was\\:\\ 0\\.013671823429833613\ \(0\)\
\-\ cm\\:\\ 0\\.01358867263527857\ \(0\)\
\-\ proteins\\:\\ 0\\.013576300938559653\ \(0\)\
\-\ lh\\:\\ 0\\.013576300938559653\ \(0\)\
\-\ dept\\:\\ 0\\.013576300938559653\ \(0\)\
\-\ typical\\:\\ 0\\.013543267565810266\ \(0\)\
\-\ investigations\\:\\ 0\\.013312404905704865\ \(0\)\
\-\ india\\:\\ 0\\.013312404905704865\ \(0\)\
\-\ images\\:\\ 0\\.01295860784149687\ \(0\)\
\-\ immunoglobulin\\:\\ 0\\.012871409745004846\ \(0\)\
\-\ acth\\:\\ 0\\.012871409745004846\ \(0\)\
\-\ pupil\\:\\ 0\\.012683049705865864\ \(0\)\
\-\ neuron\\:\\ 0\\.012683049705865864\ \(0\)\
\-\ cortisol\\:\\ 0\\.012683049705865864\ \(0\)\
\-\ erythrocyte\\:\\ 0\\.012511090462803354\ \(0\)\
\-\ sided\\:\\ 0\\.012488247482793065\ \(0\)\
\-\ attenuated\\:\\ 0\\.012352903293488064\ \(0\)\
\-\ cerebrospinal\\:\\ 0\\.012352903293488064\ \(0\)\
\-\ igm\\:\\ 0\\.012352903293488064\ \(0\)\
\-\ cortical\\:\\ 0\\.012312548816505184\ \(0\)\
\-\ antigen\\:\\ 0\\.012206444850496519\ \(0\)\
\-\ prolactin\\:\\ 0\\.012070095302103335\ \(0\)\
\-\ figures\\:\\ 0\\.011942548817641731\ \(0\)\
\-\ imaging\\:\\ 0\\.01187000291179211\ \(0\)\
\-\ tuberculous\\:\\ 0\\.011822737312075655\ \(0\)\
\-\ were\\:\\ 0\\.011503673932944197\ \(0\)\
\-\ on\\:\\ 0\\.01144491719154827\ \(0\)\
\-\ sedimentation\\:\\ 0\\.011313193617802732\ \(0\)\
\-\ sylvian\\:\\ 0\\.011225344284658791\ \(0\)\
\-\ along\\:\\ 0\\.011162268287978325\ \(0\)\
\-\ x\\:\\ 0\\.011142554685167894\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.010908461577000334\ \(0\)\
\-\ t3\\:\\ 0\\.010908461577000334\ \(0\)\
\-\ raised\\:\\ 0\\.010767238328023761\ \(0\)\
\-\ ganglion\\:\\ 0\\.010767238328023761\ \(0\)\
\-\ t1\\:\\ 0\\.010705515953455508\ \(0\)\
\-\ inversion\\:\\ 0\\.010700239214040203\ \(0\)\
\-\ advised\\:\\ 0\\.010635437192650893\ \(0\)\
\-\ depressed\\:\\ 0\\.010635437192650893\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.01051187917490122\ \(0\)\
\-\ stiffness\\:\\ 0\\.010395593601733368\ \(0\)\
\-\ cisterns\\:\\ 0\\.010395593601733368\ \(0\)\
\-\ clinical\\:\\ 0\\.010392528854015827\ \(0\)\
\-\ u\\/l\\:\\ 0\\.010285771761506468\ \(0\)\
\-\ t4\\:\\ 0\\.009898924771138693\ \(0\)\
\-\ terminal\\:\\ 0\\.009690702408178561\ \(0\)\
\-\ fluid\\:\\ 0\\.0095993640498176\ \(0\)\
\-\ weeks\\:\\ 0\\.009586078090518372\ \(0\)\
\-\ state\\:\\ 0\\.0095386054889372\ \(0\)\
\-\ figure\\:\\ 0\\.00943175327298804\ \(0\)\
\-\ a\\:\\ 0\\.009405528896883824\ \(0\)\
\-\ ruled\\:\\ 0\\.00939738223996063\ \(0\)\
\-\ illness\\:\\ 0\\.00939738223996063\ \(0\)\
\-\ palsy\\:\\ 0\\.009363598774823673\ \(0\)\
\-\ drugs\\:\\ 0\\.00933038312597707\ \(0\)\
\-\ recovery\\:\\ 0\\.009202836641515466\ \(0\)\
\-\ tsh\\:\\ 0\\.009172195956661779\ \(0\)\
\-\ fissure\\:\\ 0\\.009054173753694147\ \(0\)\
\-\ cistern\\:\\ 0\\.009025737513670234\ \(0\)\
\-\ glucose\\:\\ 0\\.009025737513670234\ \(0\)\
\-\ contributors\\:\\ 0\\.009025737513670234\ \(0\)\
\-\ occasional\\:\\ 0\\.008915915673443336\ \(0\)\
\-\ thick\\:\\ 0\\.008863211627826417\ \(0\)\
\-\ meningitis\\:\\ 0\\.008761841480815446\ \(0\)\
\-\ atrophy\\:\\ 0\\.008713041851190206\ \(0\)\
\-\ m\\:\\ 0\\.008713041851190206\ \(0\)\
\-\ vasculitis\\:\\ 0\\.00864202997524937\ \(0\)\
\-\ analysis\\:\\ 0\\.008596067797059119\ \(0\)\
\-\ esr\\:\\ 0\\.008551150304810984\ \(0\)\
\-\ 100\\:\\ 0\\.008529068683075559\ \(0\)\
\-\ pituitary\\:\\ 0\\.008464266661686249\ \(0\)\
\-\ intravenous\\:\\ 0\\.008381042382338172\ \(0\)\
\-\ diabetes\\:\\ 0\\.008360772619161908\ \(0\)\
\-\ ischemic\\:\\ 0\\.008224423070768726\ \(0\)\
\-\ medicine\\:\\ 0\\.008010562231558778\ \(0\)\
\-\ steroids\\:\\ 0\\.007944126241837464\ \(0\)\
\-\ repeat\\:\\ 0\\.007944126241837464\ \(0\)\
\-\ 3\\:\\ 0\\.007908994176705689\ \(0\)\
\-\ major\\:\\ 0\\.007895725016524626\ \(0\)\
\-\ improvement\\:\\ 0\\.00787985115941541\ \(0\)\
\-\ cavernous\\:\\ 0\\.007832980553452334\ \(0\)\
\-\ optic\\:\\ 0\\.007817600829258548\ \(0\)\
\-\ 45\\:\\ 0\\.007802339868598647\ \(0\)\
\-\ sudden\\:\\ 0\\.007802339868598647\ \(0\)\
\-\ regular\\:\\ 0\\.007787195851314914\ \(0\)\
\-\ flair\\:\\ 0\\.00774244787354859\ \(0\)\
\-\ discharged\\:\\ 0\\.00774244787354859\ \(0\)\
\-\ esophageal\\:\\ 0\\.00774244787354859\ \(0\)\
\-\ schwannoma\\:\\ 0\\.007713169047886257\ \(0\)\
\-\ disorder\\:\\ 0\\.007586530991197477\ \(0\)\
\-\ gastric\\:\\ 0\\.0075460595853802034\ \(0\)\
\-\ 22\\:\\ 0\\.007532751221385452\ \(0\)\
\-\ started\\:\\ 0\\.007532751221385452\ \(0\)\
\-\ infarct\\:\\ 0\\.007493355539763284\ \(0\)\
\-\ facial\\:\\ 0\\.007343185763127074\ \(0\)\
\-\ 2\\:\\ 0\\.0072731403024132255\ \(0\)\
\-\ right\\:\\ 0\\.007127523392177207\ \(0\)\
\-\ features\\:\\ 0\\.007126545990365765\ \(0\)\
\-\ motor\\:\\ 0\\.007052360379063265\ \(0\)\
\-\ mass\\:\\ 0\\.007046211503641687\ \(0\)\
\-\ levels\\:\\ 0\\.006970852555873444\ \(0\)\
\-\ limits\\:\\ 0\\.006960896441189735\ \(0\)\
\-\ thyroid\\:\\ 0\\.006921566096689151\ \(0\)\
\-\ at\\:\\ 0\\.006864208415997824\ \(0\)\
\-\ cells\\:\\ 0\\.006771633782905133\ \(0\)\
\-\ reveals\\:\\ 0\\.006607208992677911\ \(0\)\
\-\ marked\\:\\ 0\\.006590670949850803\ \(0\)\
\-\ rate\\:\\ 0\\.006582453538489808\ \(0\)\
\-\ malignancy\\:\\ 0\\.006525868928461493\ \(0\)\
\-\ \\<\\:\\ 0\\.006517916062256502\ \(0\)\
\-\ meningioma\\:\\ 0\\.0064942477005041\ \(0\)\
\-\ vomiting\\:\\ 0\\.006447744741195416\ \(0\)\
\-\ grade\\:\\ 0\\.006432483780535514\ \(0\)\
\-\ and\\:\\ 0\\.006403482417351645\ \(0\)\
\-\ hospital\\:\\ 0\\.006357898152110915\ \(0\)\
\-\ view\\:\\ 0\\.006336060531188811\ \(0\)\
\-\ which\\:\\ 0\\.006304919317164224\ \(0\)\
\-\ weakness\\:\\ 0\\.00627195919570827\ \(0\)\
\-\ laboratory\\:\\ 0\\.006223501454257047\ \(0\)\
\-\ above\\:\\ 0\\.006189602088197265\ \(0\)\
\-\ middle\\:\\ 0\\.00617620349731707\ \(0\)\
\-\ sinus\\:\\ 0\\.00617620349731707\ \(0\)\
\-\ biopsy\\:\\ 0\\.005991488619835495\ \(0\)\
\-\ involving\\:\\ 0\\.005925706055342477\ \(0\)\
\-\ cerebral\\:\\ 0\\.005850684786095002\ \(0\)\
\-\ fever\\:\\ 0\\.005713957759984122\ \(0\)\
\-\ left\\:\\ 0\\.00566860831584732\ \(0\)\
\-\ out\\:\\ 0\\.005581134143989162\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.005494144251861149\ \(0\)\
\-\ positive\\:\\ 0\\.005480011047992325\ \(0\)\
\-\ past\\:\\ 0\\.005366006861554217\ \(0\)\
\-\ onset\\:\\ 0\\.005330871987994367\ \(0\)\
\-\ any\\:\\ 0\\.00531785579658556\ \(0\)\
\-\ enhancing\\:\\ 0\\.005296350855503476\ \(0\)\
\-\ normal\\:\\ 0\\.005294910887743482\ \(0\)\
\-\ examination\\:\\ 0\\.005249847896194793\ \(0\)\
\-\ brain\\:\\ 0\\.005081722378068699\ \(0\)\
\-\ her\\:\\ 0\\.0050778886531322835\ \(0\)\
\-\ month\\:\\ 0\\.005066431898815433\ \(0\)\
\-\ 6\\:\\ 0\\.005043715733942439\ \(0\)\
\-\ artery\\:\\ 0\\.005028715399423318\ \(0\)\
\-\ neck\\:\\ 0\\.00495897853165708\ \(0\)\
\-\ 5\\:\\ 0\\.004941028502854077\ \(0\)\
\-\ level\\:\\ 0\\.004867369619855596\ \(0\)\
\-\ changes\\:\\ 0\\.004840015763310396\ \(0\)\
\-\ lymphoma\\:\\ 0\\.004826479514603727\ \(0\)\
\-\ following\\:\\ 0\\.004793039045259186\ \(0\)\
\-\ region\\:\\ 0\\.004769962899682435\ \(0\)\
\-\ performed\\:\\ 0\\.004708652828512488\ \(0\)\
\-\ 4\\:\\ 0\\.004705478073476373\ \(0\)\
\-\ however\\:\\ 0\\.00470230841027089\ \(0\)\
\-\ low\\:\\ 0\\.00469598429420237\ \(0\)\
\-\ history\\:\\ 0\\.004664879595680171\ \(0\)\
\-\ months\\:\\ 0\\.004612532202944796\ \(0\)\
\-\ presented\\:\\ 0\\.0046034735870008085\ \(0\)\
\-\ over\\:\\ 0\\.004299688913320084\ \(0\)\
\-\ in\\:\\ 0\\.004164004250397776\ \(0\)\
\-\ upper\\:\\ 0\\.004075257915748455\ \(0\)\
\-\ \\;\\:\\ 0\\.004002808672831213\ \(0\)\
\-\ or\\:\\ 0\\.003958587940568014\ \(0\)\
\-\ \\%\\:\\ 0\\.003939369631118592\ \(0\)\
\-\ woman\\:\\ 0\\.0039009939673693796\ \(0\)\
\-\ other\\:\\ 0\\.003892566301783495\ \(0\)\
\-\ case\\:\\ 0\\.0036946727922278076\ \(0\)\
\-\ \\-\\:\\ 0\\.0036200167168149474\ \(0\)\
\-\ findings\\:\\ 0\\.0035945393987943863\ \(0\)\
\-\ after\\:\\ 0\\.0034940735229430876\ \(0\)\
\-\ lesion\\:\\ 0\\.003439832462451491\ \(0\)\
\-\ is\\:\\ 0\\.003333739792794816\ \(0\)\
\-\ also\\:\\ 0\\.0033292877345259906\ \(0\)\
\-\ of\\:\\ 0\\.003223425318521419\ \(0\)\
\-\ within\\:\\ 0\\.0032216035738855367\ \(0\)\
\-\ be\\:\\ 0\\.002604262299098674\ \(0\)\
\-\ there\\:\\ 0\\.002513271850721321\ \(0\)\
\-\ an\\:\\ 0\\.0023353060558986755\ \(0\)\
\-\ \\:\\:\\ 0\\.0022337446956337253\ \(0\)\
\-\ year\\:\\ 0\\.0018895361052824401\ \(0\)\
\-\ old\\:\\ 0\\.001729119756644772\ \(0\)\
\-\ no\\:\\ 0\\.0017004825112723358\ \(0\)\
\-\ the\\:\\ 0\\.0016393195814659184\ \(0\)\
\-\ \\.\\:\\ 0\\.0014733009052258336\ \(0\)\
\-\ for\\:\\ 0\\.0014409251949460773\ \(0\)\
\-\ with\\:\\ 0\\.0009249341983390493\ \(0\)\
\-\ to\\:\\ 0\\.000844008119452542\ \(0\)\
